Injust20years,FagronhasdevelopedfrombeingalocalplayerintotheglobalmarketleaderandleadingconsolidatorinR&Dscientificpharmaceuticalcompounding. Over1,500employeesactivein30countriesinEurope,theAmericas,theMiddleEast,AsiaandthePacific,including200pharmacists,focusdailyonimprovingtailor-madepharmaceuticalcaretopatients.Fagronintendstofurtherreinforceitsmarketleadershipwithanactivebuy-and-buildstrategy,startingupgreenfieldsandrobustorganicgrowth. Fagron’sstrategyisfocusedontheoptimisationandinnovationofR&Dscientificpharmaceuticalcompoundingwiththeaimofwideningthetherapeuticscopeoftheprescribertoenabletailor-madepharmaceuticalcare.